^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Tolsura (SUBA-itraconazole)

i
Other names: SUBA-Cap
Associations
Company:
Inhibitor Therap, Mayne Pharma
Drug class:
Hedgehog cell-signalling pathway inhibitor
Associations
almost1year
HITMAN: Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer (clinicaltrials.gov)
P1/2, N=12, Completed, St Vincent's Hospital, Sydney | Active, not recruiting --> Completed | Trial completion date: Jul 2024 --> Oct 2023 | Trial primary completion date: Mar 2023 --> Aug 2023
Trial completion • Trial completion date • Trial primary completion date
|
hydroxychloroquine • Tolsura (SUBA-itraconazole)
over4years
Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS) (clinicaltrials.gov)
P2b, N=38, Completed, HedgePath Pharmaceuticals, Inc. | Active, not recruiting --> Completed
Clinical • Trial completion
|
GLI1 (GLI Family Zinc Finger 1)
|
GLI1 expression
|
Tolsura (SUBA-itraconazole)